feed,title,long_url,short_url
SeekingAlpha,Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million Deal,https://seekingalpha.com/article/4379613,
SeekingAlpha,U.S. IPO Weekly Recap: Solar Technology Shines In A 9-IPO Week,https://seekingalpha.com/article/4379612,
